Competition & Peer Data API & CSV Delivery

Pure Bioscience Inc's Competitiveness

Name: Pure Bioscience Inc Competitors and Peer Comparison
Creator: CSIMarket
License: https://csimarket.com/help/terms-of-use

A competitive positioning analysis and financial ratio benchmarking of Pure Bioscience Inc (PURE) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2026

Competitors Tracked

Publicly traded peers

Peer Group Market Share

100.00 %

vs 100.00 % a year ago

Revenue Growth Y/Y

3.05 %

Q3 2026

Net Margin

-123.32 %

Q3 2026

Key Findings: Pure Bioscience Inc vs Its Competitors

TTM: Trailing 12-month revenue of 2M vs -M combined for tracked competitors (100.0% combined share).
Trending: Latest-quarter revenue run-rate is decelerating (-16.4% annualized vs trailing 12 months).
Scale: Pure Bioscience Inc ranks #73 of 83 companies by market capitalization in the Chemical Manufacturing industry, holding 0.0% of industry market cap.
Peer revenue share: Pure Bioscience Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

PURE Sales vs. its Competitors, Q3 2026

Pure Bioscience Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/PURE/competitors                    

                        https://api.csimarket.com/api/v1/companies/PURE/relationships                    

                        https://api.csimarket.com/api/v1/companies/PURE/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

For context: the Chemical Manufacturing industry grew revenue 2.6% year over year, combined, vs 3.1% for Pure Bioscience Inc. Pure Bioscience Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Pure Bioscience Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity	Profitable	Expanding	Above Industry Growth	Distressed
Pure Bioscience Inc	No	Yes	Yes	No
Similar-Size Competitors (10)
Similar Growth & Profitability (8)	25.00 % (2 of 8)	75.00 % (6 of 8)	75.00 % (6 of 8)	57.10 % (4 of 7)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

PURE Stock Performance relative to its Competitors

PURE Competitors (weighted) Percent change over the selected range

Pure Bioscience Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.

Similar-Size
(2 of 8)

Similar Growth & Profitability
(2 of 8)

Entity	TTM Share Price Return (group: median)	vs U.S.A. 500
Pure Bioscience Inc	-	-
Competitors combined (0)	40.4%	63.2%
High-Confidence Competitors (0)	40.4%	63.2%
Similar-Size Competitors (8)	40.4%	63.2%
Similar Growth & Profitability (8)	40.4%	63.2%

Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Pure Bioscience Inc's competitor groups requires a Commercial License.

Unlock Commercial Access

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

PURE Stock Performance relative to Similar-Size Competitors

PURE Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

PURE Stock Performance relative to Similar Growth & Profitability Competitors

PURE Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Pure Bioscience Inc's Comment on Competition and Industry Peers

The company operates in the antimicrobial technology market, competing with established products and industry leaders. Its success depends on acquiring market share from traditional technologies, which require significant investment to replace. Products based on SDC are generally more costly to produce, which may limit customer adoption despite their efficacy and attributes such as being non-toxic and non-caustic.